2,190
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Relationship between the triglyceride–glucose index and coronary artery calcification in asymptomatic, non-diabetic patients undergoing maintenance hemodialysis

, , , , , , , , & show all
Article: 2200849 | Received 09 Dec 2022, Accepted 04 Apr 2023, Published online: 03 May 2023

References

  • Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of haemodialysis outcomes. Nat Rev Nephrol. 2022;18(6):1–7.
  • Cozzolino M, Mangano M, Stucchi A, et al. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33(suppl_3):iii28–iii34.
  • Jansz TT, Verhaar MC, London GM, et al. Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review. Clin Kidney J. 2018;11(3):353–361.
  • Disthabanchong S, Boongird S. Role of different imaging modalities of vascular calcification in predicting outcomes in chronic kidney disease. World J Nephrol. 2017;6(3):100–110.
  • Bansal N. Evolution of cardiovascular disease during the transition to end-stage renal disease. Semin Nephrol. 2017;37(2):120–131.
  • Chen J, Budoff MJ, Reilly MP, et al. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. 2017;2(6):635–643.
  • Osawa K, Nakanishi R, Budoff M. Coronary artery calcification. Glob Heart. 2016;11(3):287–293.
  • Mori H, Torii S, Kutyna M, et al. Coronary artery calcification and its progression: what does it really mean? JACC Cardiovasc Imaging. 2018;11(1):127–142.
  • Otsuka F, Sakakura K, Yahagi K, et al. Has our understanding of calcification in human coronary atherosclerosis progressed? Arterioscler Thromb Vasc Biol. 2014;34(4):724–736.
  • Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American heart association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology. Circulation. 2006;114(16):1761–1791.
  • Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291(2):210–215.
  • Wang A, Tian X, Zuo Y, et al. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):113.
  • Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575–585.
  • Yamazoe M, Hisamatsu T, Miura K, et al. Relationship of insulin resistance to prevalence and progression of coronary artery calcification beyond metabolic syndrome components: shiga epidemiological study of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 2016;36(8):1703–1708.
  • Ormazabal V, Nair S, Elfeky O, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.
  • Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293–302.
  • Navarro-González D, Sánchez-Íñigo L, Pastrana-Delgado J, et al. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: the Vascular-Metabolic CUN cohort. Prev Med. 2016;86:99–105.
  • Du T, Yuan G, Zhang M, et al. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13:146.
  • Tao LC, Xu JN, Wang TT, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.
  • Park K, Ahn CW, Lee SB, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569–1573.
  • Wang J, Huang X, Fu C, et al. Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in chinese patients with acute coronary syndrome. Cardiovasc Diabetol. 2022;21(1):187.
  • Dzaye O, Razavi AC, Dardari ZA, et al. Mean versus peak coronary calcium density on non-contrast CT: calcium scoring and ASCVD risk prediction. JACC Cardiovasc Imaging. 2022;15(3):489–500.
  • Kang SJ, Cho YR, Park GM, et al. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging. JACC Cardiovasc Imaging. 2013;6(11):1183–1190.
  • Budoff MJ, Hokanson JE, Nasir K, et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging. 2010;3(12):1229–1236.
  • Budoff MJ, Young R, Burke G, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J. 2018;39(25):2401–2408.
  • Wang MC, Lin CC, Chiang HY, et al. Association between coronary artery calcium and all-cause mortality: a large single-center retrospective cohort study. PLoS One. 2022;17(10):e0276659.
  • Reiss AB, Miyawaki N, Moon J, et al. CKD, arterial calcification, atherosclerosis and bone health: inter-relationships and controversies. Atherosclerosis. 2018;278:49–59.
  • Nakahara T, Dweck MR, Narula N, et al. Coronary artery calcification: from mechanism to molecular imaging. JACC Cardiovasc Imaging. 2017;10(5):582–593.
  • Lai J, Akindavyi G, Fu Q, et al. Research progress on the relationship between coronary artery calcification and chronic renal failure. Chin Med J (Engl). 2018;131(5): 608–614.
  • Shimoyama Y, Tsuruta Y, Niwa T. Coronary artery calcification score is associated with mortality in japanese hemodialysis patients. J Ren Nutr. 2012;22(1):139–142.
  • Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009;20(7):1453–1464.
  • Benz K, Hilgers KF, Daniel C, et al. Vascular calcification in chronic kidney disease: the role of inflammation. Int J Nephrol. 2018;2018:4310379.
  • Rask-Madsen C, Li Q, Freund B, et al. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab. 2010;11(5):379–389.
  • Chen R, Zhang L, Zhang M, et al. The triglyceride-glucose index as a novel marker associated with sarcopenia in non-diabetic patients on maintenance hemodialysis. Ren Fail. 2022;44(1):1615–1621.
  • He WY, Wu F, Pang XX, et al. Irisin is associated with urotensin II and protein energy wasting in hemodialysis patients. Kidney Blood Press Res. 2016;41(1):78–85.
  • He L, He WY, A LT, et al. Lower serum irisin levels are associated with increased vascular calcification in hemodialysis patients. Kidney Blood Press Res. 2018;43(1):287–295.
  • Won KB, Kim YS, Lee BK, et al. The relationship of insulin resistance estimated by triglyceride glucose index and coronary plaque characteristics. Medicine (Baltimore). 2018;97(21):e10726.
  • Kim MK, Ahn CW, Kang S, et al. Relationship between the triglyceride glucose index and coronary artery calcification in korean adults. Cardiovasc Diabetol. 2017;16(1):108.
  • Won KB, Park EJ, Han D, et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol. 2020;19(1):34.
  • Shemesh J, Henschke CI, Shaham D, et al. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. Radiology. 2010;257(2):541–548.